On November 28, Gelonhui announced that its wholly-owned subsidiary, Zhejiang Insigma Technology Venture Capital Co., Ltd. (hereinafter referred to as "Insigma Venture Capital"), participated in the listing on the main board of the Hong Kong Stock Exchange of its equity investee Hangzhou Jiuyuan Gene Engineering Co., Ltd. (hereinafter referred to as "Jiuyuan Gene") on November 28, 2024, with the stock code 2566. Jiuyuan Gene's global offering this time is for 45,398,800 new shares, with an issue price of HK$12.42 per share.
After the completion of Jiuyuan Gene's global offering this time, this company holds 24,513,775 shares through its wholly-owned subsidiary Insigma Venture Capital, accounting for approximately 9.99% of its total issued shares after the offering. The lock-up period for Insigma Venture Capital's holding of Jiuyuan Gene shares is 12 months after Jiuyuan Gene's listing.
